Biomarin Pharmaceutical Inc. (1BMRN)
MTA
57.88
-0.80 (-1.36%)
Real-time Data
07:00 AM
Day's Range
57.8858.50
52 wk Range
44.3663.46
Financial Statements - 1BMRN - Biomarin Pharmaceutical Inc.
Revenue
3.22B▲ 33.3%
Net Income
348.90M▼ 3.5%Net Margin 10.8%
EBITDA
572.93M▲ 5.6%
Free Cash Flow
717.01M▲ 78.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 3.22B | 2.41B |
| Cost of Goods | 717.44M | 491.49M |
| Gross Profit | 2.50B | 1.92B |
 Operating Expense | - | - |
| Operating Income | 409.49M | 401.67M |
| Non-Operating Interest | - | - |
| Other Income Expense | 8.99M | 4.51M |
| Pre Tax Income | 482.48M | 458.90M |
| Income Tax | 133.57M | 97.33M |
| Net Income | 348.90M | 361.57M |
| EPS Basic | 1.82 | 2.25 |
| EPS Diluted | 1.8 | 2.21 |
| Basic Shares Outstanding | 191.78M | 160.96M |
| Diluted Shares Outstanding | 191.78M | 160.96M |
| Ebit | 493.37M | 469.35M |
| Ebitda | 572.93M | 542.56M |
| Net Income Continuous Operations | 348.90M | 361.57M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
